Global Oncology Drugs (Oral) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Oncology Drugs (Oral) market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncology Drugs (Oral) market are covered in Chapter 9:
Bristol-Myers Squibb Company
Merck & Co., Inc
Johnson & Johnson
AstraZeneca PLC
Novartis AG
Amgen
Astellas Pharma Inc
AbbVie Inc
Pfizer Inc
F. Hoffmann-La Roche Ltd
In Chapter 5 and Chapter 7.3, based on types, the Oncology Drugs (Oral) market from 2017 to 2027 is primarily split into:
Lung Cancer
Stomach Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Kidney Cancer
Bladder Cancer
Other Cancers
In Chapter 6 and Chapter 7.4, based on applications, the Oncology Drugs (Oral) market from 2017 to 2027 covers:
Hospital Pharmacies
Retail Pharmacies/Drug Stores
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncology Drugs (Oral) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncology Drugs (Oral) Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ONCOLOGY DRUGS (ORAL) MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Drugs (Oral) Market
1.2 Oncology Drugs (Oral) Market Segment by Type
1.2.1 Global Oncology Drugs (Oral) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology Drugs (Oral) Market Segment by Application
1.3.1 Oncology Drugs (Oral) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology Drugs (Oral) Market, Region Wise (2017-2027)
1.4.1 Global Oncology Drugs (Oral) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.4 China Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.6 India Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology Drugs (Oral) (2017-2027)
1.5.1 Global Oncology Drugs (Oral) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology Drugs (Oral) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology Drugs (Oral) Market
2 INDUSTRY OUTLOOK
2.1 Oncology Drugs (Oral) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology Drugs (Oral) Market Drivers Analysis
2.4 Oncology Drugs (Oral) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology Drugs (Oral) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology Drugs (Oral) Industry Development
3 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology Drugs (Oral) Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology Drugs (Oral) Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology Drugs (Oral) Average Price by Player (2017-2022)
3.4 Global Oncology Drugs (Oral) Gross Margin by Player (2017-2022)
3.5 Oncology Drugs (Oral) Market Competitive Situation and Trends
3.5.1 Oncology Drugs (Oral) Market Concentration Rate
3.5.2 Oncology Drugs (Oral) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY DRUGS (ORAL) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology Drugs (Oral) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology Drugs (Oral) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology Drugs (Oral) Market Under COVID-19
4.5 Europe Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology Drugs (Oral) Market Under COVID-19
4.6 China Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology Drugs (Oral) Market Under COVID-19
4.7 Japan Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology Drugs (Oral) Market Under COVID-19
4.8 India Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology Drugs (Oral) Market Under COVID-19
4.9 Southeast Asia Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology Drugs (Oral) Market Under COVID-19
4.10 Latin America Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology Drugs (Oral) Market Under COVID-19
4.11 Middle East and Africa Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology Drugs (Oral) Market Under COVID-19
5 GLOBAL ONCOLOGY DRUGS (ORAL) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology Drugs (Oral) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology Drugs (Oral) Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology Drugs (Oral) Price by Type (2017-2022)
5.4 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Lung Cancer (2017-2022)
5.4.2 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Stomach Cancer (2017-2022)
5.4.3 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Colorectal Cancer (2017-2022)
5.4.4 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Breast Cancer (2017-2022)
5.4.5 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Prostate Cancer (2017-2022)
5.4.6 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Liver Cancer (2017-2022)
5.4.7 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Esophagus Cancer (2017-2022)
5.4.8 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Cervical Cancer (2017-2022)
5.4.9 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Kidney Cancer (2017-2022)
5.4.10 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Bladder Cancer (2017-2022)
5.4.11 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Other Cancers (2017-2022)
6 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology Drugs (Oral) Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology Drugs (Oral) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology Drugs (Oral) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology Drugs (Oral) Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
6.3.2 Global Oncology Drugs (Oral) Consumption and Growth Rate of Retail Pharmacies/Drug Stores (2017-2022)
6.3.3 Global Oncology Drugs (Oral) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET FORECAST (2022-2027)
7.1 Global Oncology Drugs (Oral) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology Drugs (Oral) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology Drugs (Oral) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology Drugs (Oral) Price and Trend Forecast (2022-2027)
7.2 Global Oncology Drugs (Oral) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology Drugs (Oral) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology Drugs (Oral) Revenue and Growth Rate of Lung Cancer (2022-2027)
7.3.2 Global Oncology Drugs (Oral) Revenue and Growth Rate of Stomach Cancer (2022-2027)
7.3.3 Global Oncology Drugs (Oral) Revenue and Growth Rate of Colorectal Cancer (2022-2027)
7.3.4 Global Oncology Drugs (Oral) Revenue and Growth Rate of Breast Cancer (2022-2027)
7.3.5 Global Oncology Drugs (Oral) Revenue and Growth Rate of Prostate Cancer (2022-2027)
7.3.6 Global Oncology Drugs (Oral) Revenue and Growth Rate of Liver Cancer (2022-2027)
7.3.7 Global Oncology Drugs (Oral) Revenue and Growth Rate of Esophagus Cancer (2022-2027)
7.3.8 Global Oncology Drugs (Oral) Revenue and Growth Rate of Cervical Cancer (2022-2027)
7.3.9 Global Oncology Drugs (Oral) Revenue and Growth Rate of Kidney Cancer (2022-2027)
7.3.10 Global Oncology Drugs (Oral) Revenue and Growth Rate of Bladder Cancer (2022-2027)
7.3.11 Global Oncology Drugs (Oral) Revenue and Growth Rate of Other Cancers (2022-2027)
7.4 Global Oncology Drugs (Oral) Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.4.2 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Retail Pharmacies/Drug Stores(2022-2027)
7.4.3 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Oncology Drugs (Oral) Market Forecast Under COVID-19
8 ONCOLOGY DRUGS (ORAL) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology Drugs (Oral) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology Drugs (Oral) Analysis
8.6 Major Downstream Buyers of Oncology Drugs (Oral) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology Drugs (Oral) Industry
9 PLAYERS PROFILES
9.1 Bristol-Myers Squibb Company
9.1.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.1.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc
9.2.1 Merck & Co., Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.2.3 Merck & Co., Inc Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.3.3 Johnson & Johnson Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 AstraZeneca PLC
9.4.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.4.3 AstraZeneca PLC Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Amgen
9.6.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.6.3 Amgen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Astellas Pharma Inc
9.7.1 Astellas Pharma Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.7.3 Astellas Pharma Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 AbbVie Inc
9.8.1 AbbVie Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.8.3 AbbVie Inc Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Pfizer Inc
9.9.1 Pfizer Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.9.3 Pfizer Inc Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 F. Hoffmann-La Roche Ltd
9.10.1 F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.10.3 F. Hoffmann-La Roche Ltd Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Oncology Drugs (Oral) Market
1.2 Oncology Drugs (Oral) Market Segment by Type
1.2.1 Global Oncology Drugs (Oral) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology Drugs (Oral) Market Segment by Application
1.3.1 Oncology Drugs (Oral) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology Drugs (Oral) Market, Region Wise (2017-2027)
1.4.1 Global Oncology Drugs (Oral) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.4 China Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.6 India Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology Drugs (Oral) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology Drugs (Oral) (2017-2027)
1.5.1 Global Oncology Drugs (Oral) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology Drugs (Oral) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology Drugs (Oral) Market
2 INDUSTRY OUTLOOK
2.1 Oncology Drugs (Oral) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology Drugs (Oral) Market Drivers Analysis
2.4 Oncology Drugs (Oral) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology Drugs (Oral) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology Drugs (Oral) Industry Development
3 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology Drugs (Oral) Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology Drugs (Oral) Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology Drugs (Oral) Average Price by Player (2017-2022)
3.4 Global Oncology Drugs (Oral) Gross Margin by Player (2017-2022)
3.5 Oncology Drugs (Oral) Market Competitive Situation and Trends
3.5.1 Oncology Drugs (Oral) Market Concentration Rate
3.5.2 Oncology Drugs (Oral) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY DRUGS (ORAL) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology Drugs (Oral) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology Drugs (Oral) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology Drugs (Oral) Market Under COVID-19
4.5 Europe Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology Drugs (Oral) Market Under COVID-19
4.6 China Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology Drugs (Oral) Market Under COVID-19
4.7 Japan Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology Drugs (Oral) Market Under COVID-19
4.8 India Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology Drugs (Oral) Market Under COVID-19
4.9 Southeast Asia Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology Drugs (Oral) Market Under COVID-19
4.10 Latin America Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology Drugs (Oral) Market Under COVID-19
4.11 Middle East and Africa Oncology Drugs (Oral) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology Drugs (Oral) Market Under COVID-19
5 GLOBAL ONCOLOGY DRUGS (ORAL) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology Drugs (Oral) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology Drugs (Oral) Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology Drugs (Oral) Price by Type (2017-2022)
5.4 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Lung Cancer (2017-2022)
5.4.2 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Stomach Cancer (2017-2022)
5.4.3 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Colorectal Cancer (2017-2022)
5.4.4 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Breast Cancer (2017-2022)
5.4.5 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Prostate Cancer (2017-2022)
5.4.6 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Liver Cancer (2017-2022)
5.4.7 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Esophagus Cancer (2017-2022)
5.4.8 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Cervical Cancer (2017-2022)
5.4.9 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Kidney Cancer (2017-2022)
5.4.10 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Bladder Cancer (2017-2022)
5.4.11 Global Oncology Drugs (Oral) Sales Volume, Revenue and Growth Rate of Other Cancers (2017-2022)
6 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology Drugs (Oral) Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology Drugs (Oral) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology Drugs (Oral) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology Drugs (Oral) Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
6.3.2 Global Oncology Drugs (Oral) Consumption and Growth Rate of Retail Pharmacies/Drug Stores (2017-2022)
6.3.3 Global Oncology Drugs (Oral) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ONCOLOGY DRUGS (ORAL) MARKET FORECAST (2022-2027)
7.1 Global Oncology Drugs (Oral) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology Drugs (Oral) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology Drugs (Oral) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology Drugs (Oral) Price and Trend Forecast (2022-2027)
7.2 Global Oncology Drugs (Oral) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology Drugs (Oral) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology Drugs (Oral) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology Drugs (Oral) Revenue and Growth Rate of Lung Cancer (2022-2027)
7.3.2 Global Oncology Drugs (Oral) Revenue and Growth Rate of Stomach Cancer (2022-2027)
7.3.3 Global Oncology Drugs (Oral) Revenue and Growth Rate of Colorectal Cancer (2022-2027)
7.3.4 Global Oncology Drugs (Oral) Revenue and Growth Rate of Breast Cancer (2022-2027)
7.3.5 Global Oncology Drugs (Oral) Revenue and Growth Rate of Prostate Cancer (2022-2027)
7.3.6 Global Oncology Drugs (Oral) Revenue and Growth Rate of Liver Cancer (2022-2027)
7.3.7 Global Oncology Drugs (Oral) Revenue and Growth Rate of Esophagus Cancer (2022-2027)
7.3.8 Global Oncology Drugs (Oral) Revenue and Growth Rate of Cervical Cancer (2022-2027)
7.3.9 Global Oncology Drugs (Oral) Revenue and Growth Rate of Kidney Cancer (2022-2027)
7.3.10 Global Oncology Drugs (Oral) Revenue and Growth Rate of Bladder Cancer (2022-2027)
7.3.11 Global Oncology Drugs (Oral) Revenue and Growth Rate of Other Cancers (2022-2027)
7.4 Global Oncology Drugs (Oral) Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.4.2 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Retail Pharmacies/Drug Stores(2022-2027)
7.4.3 Global Oncology Drugs (Oral) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Oncology Drugs (Oral) Market Forecast Under COVID-19
8 ONCOLOGY DRUGS (ORAL) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology Drugs (Oral) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology Drugs (Oral) Analysis
8.6 Major Downstream Buyers of Oncology Drugs (Oral) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology Drugs (Oral) Industry
9 PLAYERS PROFILES
9.1 Bristol-Myers Squibb Company
9.1.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.1.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc
9.2.1 Merck & Co., Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.2.3 Merck & Co., Inc Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.3.3 Johnson & Johnson Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 AstraZeneca PLC
9.4.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.4.3 AstraZeneca PLC Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Amgen
9.6.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.6.3 Amgen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Astellas Pharma Inc
9.7.1 Astellas Pharma Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.7.3 Astellas Pharma Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 AbbVie Inc
9.8.1 AbbVie Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.8.3 AbbVie Inc Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Pfizer Inc
9.9.1 Pfizer Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.9.3 Pfizer Inc Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 F. Hoffmann-La Roche Ltd
9.10.1 F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology Drugs (Oral) Product Profiles, Application and Specification
9.10.3 F. Hoffmann-La Roche Ltd Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Oncology Drugs (Oral) Product Picture
Table Global Oncology Drugs (Oral) Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology Drugs (Oral) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology Drugs (Oral) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology Drugs (Oral) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology Drugs (Oral) Industry Development
Table Global Oncology Drugs (Oral) Sales Volume by Player (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Share by Player (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Share by Player in 2021
Table Oncology Drugs (Oral) Revenue (Million USD) by Player (2017-2022)
Table Oncology Drugs (Oral) Revenue Market Share by Player (2017-2022)
Table Oncology Drugs (Oral) Price by Player (2017-2022)
Table Oncology Drugs (Oral) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Drugs (Oral) Sales Volume, Region Wise (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise in 2021
Table Global Oncology Drugs (Oral) Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology Drugs (Oral) Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share, Region Wise in 2021
Table Global Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume by Type (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share by Type in 2021
Table Global Oncology Drugs (Oral) Revenue (Million USD) by Type (2017-2022)
Table Global Oncology Drugs (Oral) Revenue Market Share by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share by Type in 2021
Table Oncology Drugs (Oral) Price by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Lung Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Stomach Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Colorectal Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Breast Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Prostate Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Liver Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Esophagus Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Cervical Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Kidney Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Bladder Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Other Cancers (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2017-2022)
Table Global Oncology Drugs (Oral) Consumption by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Market Share by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Retail Pharmacies/Drug Stores (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Others (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology Drugs (Oral) Price and Trend Forecast (2022-2027)
Figure USA Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology Drugs (Oral) Market Sales Volume Forecast, by Type
Table Global Oncology Drugs (Oral) Sales Volume Market Share Forecast, by Type
Table Global Oncology Drugs (Oral) Market Revenue (Million USD) Forecast, by Type
Table Global Oncology Drugs (Oral) Revenue Market Share Forecast, by Type
Table Global Oncology Drugs (Oral) Price Forecast, by Type
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2022-2027)
Table Global Oncology Drugs (Oral) Market Consumption Forecast, by Application
Table Global Oncology Drugs (Oral) Consumption Market Share Forecast, by Application
Table Global Oncology Drugs (Oral) Market Revenue (Million USD) Forecast, by Application
Table Global Oncology Drugs (Oral) Revenue Market Share Forecast, by Application
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Retail Pharmacies/Drug Stores (2022-2027)
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Oncology Drugs (Oral) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Merck & Co., Inc Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure AstraZeneca PLC Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc Profile
Table Astellas Pharma Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Astellas Pharma Inc Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc Profile
Table AbbVie Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure AbbVie Inc Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc Profile
Table Pfizer Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Pfizer Inc Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd Profile
Table F. Hoffmann-La Roche Ltd Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd Revenue (Million USD) Market Share 2017-2022
Figure Oncology Drugs (Oral) Product Picture
Table Global Oncology Drugs (Oral) Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology Drugs (Oral) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology Drugs (Oral) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology Drugs (Oral) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology Drugs (Oral) Industry Development
Table Global Oncology Drugs (Oral) Sales Volume by Player (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Share by Player (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Share by Player in 2021
Table Oncology Drugs (Oral) Revenue (Million USD) by Player (2017-2022)
Table Oncology Drugs (Oral) Revenue Market Share by Player (2017-2022)
Table Oncology Drugs (Oral) Price by Player (2017-2022)
Table Oncology Drugs (Oral) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Drugs (Oral) Sales Volume, Region Wise (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share, Region Wise in 2021
Table Global Oncology Drugs (Oral) Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology Drugs (Oral) Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share, Region Wise in 2021
Table Global Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume by Type (2017-2022)
Table Global Oncology Drugs (Oral) Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume Market Share by Type in 2021
Table Global Oncology Drugs (Oral) Revenue (Million USD) by Type (2017-2022)
Table Global Oncology Drugs (Oral) Revenue Market Share by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue Market Share by Type in 2021
Table Oncology Drugs (Oral) Price by Type (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Lung Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Stomach Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Colorectal Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Breast Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Prostate Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Liver Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Esophagus Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Cervical Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Kidney Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Bladder Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate of Other Cancers (2017-2022)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2017-2022)
Table Global Oncology Drugs (Oral) Consumption by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Market Share by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Retail Pharmacies/Drug Stores (2017-2022)
Table Global Oncology Drugs (Oral) Consumption and Growth Rate of Others (2017-2022)
Figure Global Oncology Drugs (Oral) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology Drugs (Oral) Price and Trend Forecast (2022-2027)
Figure USA Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology Drugs (Oral) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology Drugs (Oral) Market Sales Volume Forecast, by Type
Table Global Oncology Drugs (Oral) Sales Volume Market Share Forecast, by Type
Table Global Oncology Drugs (Oral) Market Revenue (Million USD) Forecast, by Type
Table Global Oncology Drugs (Oral) Revenue Market Share Forecast, by Type
Table Global Oncology Drugs (Oral) Price Forecast, by Type
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Lung Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Stomach Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Colorectal Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Breast Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Liver Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Esophagus Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Cervical Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2022-2027)
Figure Global Oncology Drugs (Oral) Revenue (Million USD) and Growth Rate of Other Cancers (2022-2027)
Table Global Oncology Drugs (Oral) Market Consumption Forecast, by Application
Table Global Oncology Drugs (Oral) Consumption Market Share Forecast, by Application
Table Global Oncology Drugs (Oral) Market Revenue (Million USD) Forecast, by Application
Table Global Oncology Drugs (Oral) Revenue Market Share Forecast, by Application
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Retail Pharmacies/Drug Stores (2022-2027)
Figure Global Oncology Drugs (Oral) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Oncology Drugs (Oral) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Merck & Co., Inc Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure AstraZeneca PLC Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc Profile
Table Astellas Pharma Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Astellas Pharma Inc Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc Profile
Table AbbVie Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure AbbVie Inc Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc Profile
Table Pfizer Inc Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure Pfizer Inc Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd Profile
Table F. Hoffmann-La Roche Ltd Oncology Drugs (Oral) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs (Oral) Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd Revenue (Million USD) Market Share 2017-2022
